Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

Publisher: John Wiley & Sons Inc

E-ISSN: 2326-5205|67|8|2011-2019

ISSN: 2326-5191

Source: ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.8, 2015-05, pp. : 2011-2019

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content